Virtu Financial LLC Takes Position in Jaguar Health, Inc. (NASDAQ:JAGX)

Virtu Financial LLC acquired a new position in Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.28% of Jaguar Health as of its most recent SEC filing.

Separately, Perritt Capital Management Inc acquired a new position in Jaguar Health during the second quarter worth about $90,000. 12.04% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a research note on Friday, September 13th.

Jaguar Health Price Performance

NASDAQ JAGX opened at $0.93 on Friday. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36. Jaguar Health, Inc. has a fifty-two week low of $0.84 and a fifty-two week high of $21.60. The business has a fifty day moving average of $1.05 and a 200-day moving average of $1.81.

Jaguar Health Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.